Question follow-through · 10911
Brain Cancer: Research
To ask the Secretary of State for Health and Social Care, with reference to the answer of 10 November 2025 to Question 78821, whether additional resources have been allocated to research on (a) Giloma, (b) Glioblastoma, (c) Astrocytoma, (d) DIPG and (e) D
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 17 Jun 2026
- Target answer date
- 22 Jun 2026
- Answer
- 29 Jun 2026 · 12 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
17 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, with reference to the answer of 10 November 2025 to Question 78821, whether additional resources have been allocated to research on (a) Giloma, (b) Glioblastoma, (c) Astrocytoma, (d) DIPG and (e) D
22 Jun 2026
Target answer date
Date supplied by the official written-questions record.
29 Jun 2026
Answer published
I refer the hon. Member to the answer I gave to the hon. Member Ruislip, Northwood and Pinner on 10 November 2025 to Question 78821. As investment for cancer research is calculated retrospectively, with a time lag due to annual reporting cycles, 2024/25 i...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.